Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVSEF - ADC Therapeutics Cuts Price In 2nd IPO Attempt


NVSEF - ADC Therapeutics Cuts Price In 2nd IPO Attempt

Quick Take

ADC Therapeutics (ADCT) intends to raise $125 million from the sale of its common stock, per an amended registration statement.

The company is advancing a pipeline of drug candidates for the treatment of blood cancers and solid tumors.

ADCT is making a new attempt to go public at a reasonable valuation and with strong existing investor interest in supporting the IPO.

Company & Technology

Epalinges, Switzerland-based ADC was founded as a spin-off of Spirogen to develop antibody drug conjugates (ADCs - hence the company's name) for the treatment of hematological

Read more ...

Stock Information

Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com

Menu

NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...